Biomarkers Overview
JH · Effective Oct 1, 2015
13 active Medicare policies list 81535, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Jul 17, 2023
JH · Effective Jul 17, 2023
JL · Effective Jul 17, 2023
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
J6
JK · Effective Oct 1, 2015
JK
6 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 81535 |
|---|---|---|
| Multianalyte Assays with Algorithmic Analyses for Cancer Indications | May 1, 2026 | Covered with conditions |
| Pharmacogenomics Testing | Sep 9, 2026 | Covered |
| Pharmacogenomics Testing | Jul 22, 2026 | Covered |
| Policy | Effective | Status of 81535 |
|---|---|---|
| Tumor Chemosensitivity Assays |
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
J6 · Effective Jul 15, 2026
| Mar 29, 2023 |
| Covered |
| Policy | Effective | Status of 81535 |
|---|---|---|
| Concert Genetic Testing Oncology: Algorithmic Assays | Not recorded | Referenced |
| Policy | Effective | Status of 81535 |
|---|---|---|
| In Vitro Chemoresistance and Chemosensitivity Assays | Apr 1, 2026 | Covered |